- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03411187
Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy
17. september 2018 opdateret af: Bo Wang,MD
Endoscopic thyroidectomy developed rapidly in recent years, and the most popular surgical approach was endoscopic thyroidectomy by bilateral areola approach, but some operative steps was required optimization.
One of the most annoying problem was the smog blurring endoscopic lens during surgery.
The researcher summarized a set of convenient foot-control exhaust method and carried out this prospective study.
Studieoversigt
Status
Ukendt
Intervention / Behandling
Detaljeret beskrivelse
The patients with papillary thyroid microcarcinoma were included according to the inclusive criteria and randomly divided them into two groups (foot-control exhaust group and direct exhaust group).
The foot-control exhaust group used the foot-control exhaust method by the way of adjustable Pressure to intermittent exhaust, while direct exhaust group exhaust through the Trocar hole.
Comparison of operation time, times of wiping the endoscopic lens, volume of postoperative drainage, and number of identified parathyroid gland between two groups.
Undersøgelsestype
Interventionel
Tilmelding (Forventet)
100
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Fujian
-
Fuzhou, Fujian, Kina, 350001
- Rekruttering
- Wen-xin ZHAO
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 70 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Patients with maximum tumor diameter ≤1 cm;
- patients without lateral neck lymph node metastases;
- patients without distant metastases;
- patients who only needed unilateral surgery following the guidelines;
- patients with strong cosmetic requirement.
Exclusion criteria:
- Patients with maximum tumor diameter >1 cm;
- patients who needed complement total thyroidectomy according to the guidelines, including tumor extrathyroidal extension as well as large amount of neck lymph node metastases and distant metastases;
- patients without cosmetic requirements.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: foot-control exhaust group
The foot-control exhaust group used of the Pressure adjustable foot-control method by the way of adjustable Pressure to intermittent exhaust
|
Whether The Pressure adjustable foot-control method is used.
|
Placebo komparator: direct exhaust group
direct exhaust group exhaust through the Trocar hole.and
without use of the Pressure adjustable foot-control method
|
direct exhaust through the trocar.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Flap separation time
Tidsramme: 1 day after surgery
|
Flap separation time was acquired from endoscopic video was the period from endoscopy into the body to building up operation space.
|
1 day after surgery
|
Glandular excision time
Tidsramme: 1 day after surgery
|
Glandular excision time was defined from incising cervical white line to removing Berry ligament.
|
1 day after surgery
|
Central lymph node dissection time
Tidsramme: 1 day after surgery
|
Central lymph node dissection time: was from separating central lymph node to the specimen removed.
|
1 day after surgery
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Times of wiping lens
Tidsramme: 1 day after surgery
|
Times of wiping lens calculated from endoscopic video after operation was defined the times of wiping lens from endoscopy into the body to central lymph node removed.
|
1 day after surgery
|
Volume of intraoperative blood loss
Tidsramme: 1 day after surgery
|
Volume of intraoperative blood loss was estimated the volume of intraoperative blood loss.
|
1 day after surgery
|
Volume of Postoperative drainage
Tidsramme: 1 day,2 day,3 day after surgery
|
Volume of Postoperative drainage was accurately calculated the total volume while the drainage tube removed after operation.
|
1 day,2 day,3 day after surgery
|
The number of identifying parathyroid glands
Tidsramme: 1 day after surgery
|
The number of identifying parathyroid glands was evaluated at postoperation while parathyroid glands was identified during surgery.
|
1 day after surgery
|
Blood PTH level
Tidsramme: preoperative, first day after operation, one week after surgery, two months after surgery.
|
measurement of PTH level in blood
|
preoperative, first day after operation, one week after surgery, two months after surgery.
|
Blood calcium level
Tidsramme: before surgery, the first day after surgery, one week after surgery, two months after surgery.
|
to measure the blood calcium level in the blood
|
before surgery, the first day after surgery, one week after surgery, two months after surgery.
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. januar 2018
Primær færdiggørelse (Faktiske)
30. juni 2018
Studieafslutning (Forventet)
30. december 2018
Datoer for studieregistrering
Først indsendt
19. januar 2018
Først indsendt, der opfyldte QC-kriterier
25. januar 2018
Først opslået (Faktiske)
26. januar 2018
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
18. september 2018
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
17. september 2018
Sidst verificeret
1. september 2018
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Neoplasmer efter histologisk type
- Neoplasmer
- Neoplasmer efter sted
- Adenocarcinom
- Karcinom
- Neoplasmer, kirtel og epitel
- Sygdomme i det endokrine system
- Neoplasmer i endokrine kirtler
- Neoplasmer i hoved og hals
- Adenocarcinom, papillært
- Skjoldbruskkirtelsygdomme
- Thyroidneoplasmer
- Kræft i skjoldbruskkirtlen, papillær
Andre undersøgelses-id-numre
- exhaust
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .